Recruiting
PET-MRI Esophagus Feasibility Study
NCT05796102
- Conditions
- Esophagogastric Cancer
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Esophagogastric Cancer
Explore clinical trials studying Esophagogastric Cancer. Study availability and eligibility vary by location and protocol.
11 public trials
2 recruiting studies
Esophagogastric Cancer trial results
NCT04656041
- Conditions
- Esophagogastric Cancer, Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital at Newton Wellesley Hospital Newton, Massachusetts, United States
Active, not recruiting
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing
NCT03133650
- Conditions
- Esophagogastric Cancer, Moderate to Severe Dysphagia
- Locations
-
- Memorial Sloan - Kettering Cancer Center New York, United States
- Weill Cornell Medical Center (Data Analysis Only) New York, United States
- Weizmann Institute of Science Rehovot, Israel
Active, not recruiting
A Study of Tooth Erosion in People With Esophagogastric Cancer
NCT05612048
- Conditions
- Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +9 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Active, not recruiting
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
NCT04757363
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +8 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
Active, not recruiting
A Study of Amivantamab in People With Esophagogastric Cancer
NCT05117931
- Conditions
- Esophagogastric Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- University of California, Irvine Irvine, California, United States
- Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge (Limited protocol activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
Active, not recruiting
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
- Locations
-
- Massachusetts General Hospital . Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT04161781
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02023996
- Conditions
- Esophagogastric Cancer
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01167114
- Conditions
- Esophagogastric Cancer
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States